Providing further support for an association between ductal histology and MMR deficiency, we found that two of three patients with MMR-deficient hypermutated metastatic prostate cancer whose primary tumors were available for review had dPC. The gene discussed is MRC1; the disease is metastatic prostate carcinoma.